Financhill
Back

Immuneering Corp. Stock Predictions

Immuneering Corp. Stock Forecast

  • Over the next 52 weeks, Immuneering Corp. has on average historically risen by 34.7% based on the past 4 years of stock performance.
  • Immuneering Corp. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Immuneering Corp. Stock Undervalued?
    The current Immuneering Corp. [IMRX] share price is $5.67. The Score for IMRX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • IMRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Immuneering Corp. Stock Go Up Next Year?

  • Over the next 52 weeks, Immuneering Corp. has on average historically risen by 34.7% based on the past 4 years of stock performance.

Immuneering Corp. Stock Rating

Sell
24
Immuneering Corp. (IMRX) is a Sell

Is Immuneering Corp. overpriced?

  • Immuneering Corp. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Immuneering Corp. Stock Price History

Is IMRX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMRX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immuneering.com

52-Week Data

52-Week High:
10.08
52-Week Low:
1.10

Prediction Charts

Market Cap:
366.1M
Price in USD:
5.67
Volume:
1.1M
Beta:
0.47

Technical Analysis

SMA50:
6.43
SMA100:
6.11
SMA200:
4.13
52-Wk Change:
250%

Stock Predictions

  • Is Immuneering Corp. stock public?
    Yes, Immuneering Corp. is a publicly traded company.
  • What is the Immuneering Corp. stock quote today?
    The Immuneering Corp. stock price is 5.67 USD today.
  • How to buy Immuneering Corp. stock online?
    You can buy Immuneering Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-1 7.58 7.09 7.58 6.94
Dec-2 7.06 6.69 7.21 6.69
Dec-3 6.71 6.74 6.78 6.42
Dec-4 6.76 6.69 6.81 6.60
Dec-5 6.63 6.40 6.71 6.35
Dec-8 6.40 6.52 6.73 6.38
Dec-9 6.46 6.24 6.58 6.20
Dec-10 6.21 6.16 6.21 5.93
Dec-11 6.09 6.20 6.54 6.03
Dec-12 6.21 6.08 6.41 6.07
Dec-15 6.19 5.78 6.19 5.73
Dec-16 5.74 5.74 5.95 5.62
Dec-17 5.72 5.50 5.79 5.45
Dec-18 5.53 5.67 5.95 5.53

Immuneering Corp. Earnings

Immuneering Corp. Earnings Report: Per Share Immuneering Corp. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immuneering Corp. Forecast Revenue Growth

Immuneering Corp. Stock Analysis: Historical quarterly revenues per share for Immuneering Corp. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.18 per share.

* Immuneering Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.